Your browser doesn't support javascript.
loading
Generation of the human iPSC line ESi082-A from a patient with macular dystrophy associated to mutations in the CRB1 gene.
Cañibano-Hernández, Alberto; Valdes-Sanchez, Lourdes; Garcia-Delgado, Ana B; Ponte-Zúñiga, Beatriz; Diaz-Corrales, Francisco J; de la Cerda, Berta.
Afiliación
  • Cañibano-Hernández A; Department of Regeneration and Cell Therapy, Andalusian Molecular Biology and Regenerative Medicine Centre (CABIMER), Avda. Americo Vespucio, 24, 41092 Seville, Spain.
  • Valdes-Sanchez L; Department of Regeneration and Cell Therapy, Andalusian Molecular Biology and Regenerative Medicine Centre (CABIMER), Avda. Americo Vespucio, 24, 41092 Seville, Spain.
  • Garcia-Delgado AB; Department of Regeneration and Cell Therapy, Andalusian Molecular Biology and Regenerative Medicine Centre (CABIMER), Avda. Americo Vespucio, 24, 41092 Seville, Spain.
  • Ponte-Zúñiga B; University Hospital Virgen Macarena, RETICS Oftared, Carlos III Institute of Health (Spain), Ministry of Health RD16/0008/0010, Seville, Spain.
  • Diaz-Corrales FJ; Department of Regeneration and Cell Therapy, Andalusian Molecular Biology and Regenerative Medicine Centre (CABIMER), Avda. Americo Vespucio, 24, 41092 Seville, Spain.
  • de la Cerda B; Department of Regeneration and Cell Therapy, Andalusian Molecular Biology and Regenerative Medicine Centre (CABIMER), Avda. Americo Vespucio, 24, 41092 Seville, Spain. Electronic address: berta.delacerda@cabimer.es.
Stem Cell Res ; 53: 102301, 2021 05.
Article en En | MEDLINE | ID: mdl-33773389

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Células Madre Pluripotentes Inducidas / Distrofias Retinianas / Degeneración Macular Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Stem Cell Res Año: 2021 Tipo del documento: Article País de afiliación: España

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Células Madre Pluripotentes Inducidas / Distrofias Retinianas / Degeneración Macular Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Stem Cell Res Año: 2021 Tipo del documento: Article País de afiliación: España